Mark Harrison

3.2k citations
65 papers · 2.5k · 1 hit paper · h-index 25

Impact in

  • Oncology top 2%
    • Colorectal Cancer Surgical Treatments
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Gastric Cancer Management and Outcomes

Papers in

    • Colorectal Cancer Surgical Treatments 25
    • Colorectal Cancer Treatments and Studies 13
    • Pancreatic and Hepatic Oncology Research 2
    • Colorectal and Anal Carcinomas 14
    • Esophageal Cancer Research and Treatment 4

Mark Harrison

62 papers receiving 2.4k citations

Mark Harrison's Hit Papers

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial 2014 · 270 citations
2700+4+8Years since publication50100150200250

Peers

Mark Harrison
Comparison fields: 5 of 69
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 443
  • Surgery 576
  • Radiation 71
  • Cancer Research 63
Replace Rosella Spadi with:
Rosella Spadi Italy
Qingsong Pang China
David Borg Sweden
G.J. Creemers Netherlands
Rebecca S. Slack Tidwell United States
Carolyn Kay McCourt United States
Claudia Caserta Italy
Philip Philip United States
Luis Paz Ares Spain
Béata Juzyna France
Mark Harrison relative to Rosella Spadi Italy Rosella Spadi's profile →
Citations per field
00.5×2×2.6×
Rosella Spadi · 1×
Citations per year

Countries citing papers authored by Mark Harrison

Since Specialization
Citations

This map shows the geographic impact of Mark Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harrison more than expected).

Fields of papers citing papers by Mark Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harrison. The network helps show where Mark Harrison may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Harrison Line = papers co-authored together Mark Harrison links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014327
2
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial
Hit paper breakdown →
2014270
3 2014232
4 2018142
5 2014109
6 2017106
7 2005105
8 200589
9 201381
10 200679
11 201272
12 201063
13 201048
14 201248
15 201648
16 201845
17 201243
18 201438
19 201638
20 200737

About Mark Harrison

Mark Harrison is a scholar working on Oncology, Surgery, Radiation, Pulmonary and Respiratory Medicine and Economics and Econometrics, having authored 65 papers that have together received 2.5k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (25 papers), Colorectal and Anal Carcinomas (14 papers), Colorectal Cancer Treatments and Studies (13 papers), Advanced Radiotherapy Techniques (7 papers), Esophageal Cancer Research and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (443 citations), Surgery (576 citations), Radiation (71 citations) and Cancer Research (63 citations). Mark Harrison has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Rob Glynne‐Jones, Richard Adams, David Sebag‐Montefiore, Neel J. Bhuva, Andreas Makris, J. Grainger, Maria Andreia Hawkins, Rebecca Muirhead, Duncan Charles Gilbert and Mark P. Saunders. Their work appears in journals such as Annals of Oncology, The Lancet Oncology, Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact